Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A double-blind, randomized, placebo (maltodextrin)-controlled crossover phase I/II trial (with a 4-week washout period between interventions) evaluating Galacto-oligosaccharides (GOS Bimuno) in 45 overweight adults with three risk factors associated with metabolic syndrome
Outcome measures:
Markers of metabolic syndrome and immune function
The conclusion from the authors was: Administration of B-GOS to overweight adults resulted in positive effects on the composition of the gut microbiota, the immune response, and insulin, TC, and TG concentrations. B-GOS may be a useful candidate for the enhancement of gastrointestinal health, immune function, and the reduction of metabolic syndrome risk fa…